Page last updated: 2024-10-30

mefenamic acid and Hypertension

mefenamic acid has been researched along with Hypertension in 3 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research Excerpts

ExcerptRelevanceReference
"Mefenamic acid was without effect on ACh-induced relaxations in either the arterial or the venous beds from WKY and SHR."1.30Comparison of the nitric oxide and cyclo-oxygenase pathway in mesenteric resistance vessels of normotensive and spontaneously hypertensive rats. ( Finet, M; Le Marquer-Domagala, F, 1997)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, YH1
Chang, CH1
Wu, LC1
Hwang, JS1
Toh, S1
Le Marquer-Domagala, F1
Finet, M1
Khazine, F1
Simons, O1

Other Studies

3 other studies available for mefenamic acid and Hypertension

ArticleYear
Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:5

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular System; Celecoxib; Cyclooxygenase 2 In

2018
Comparison of the nitric oxide and cyclo-oxygenase pathway in mesenteric resistance vessels of normotensive and spontaneously hypertensive rats.
    British journal of pharmacology, 1997, Volume: 121, Issue:3

    Topics: Acetylcholine; Animals; Blood Pressure; Cholic Acids; Hypertension; Male; Mefenamic Acid; Mesenteric

1997
[A possible adverse effect from the association of losartan-mefenamic acid in hemodialysis].
    Nephrologie, 2001, Volume: 22, Issue:2

    Topics: Adult; Antihypertensive Agents; Atenolol; Cyclooxygenase Inhibitors; Drug Interactions; Drug Therapy

2001